Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02347618 · ClinicalTrials.gov registry record · NA
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02347618 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 18 participants.
The verdict
NCT02347618, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a short-course of stereotactic body radiotherapy (SBRT) prior to surgical resection of pancreatic adenocarcinoma is feasible and well-tolerated.
Interventions
- RADIATION Preoperative SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-12 |
| Est. Completion | 2022-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02347618
The ClinicalTrials.gov registry entry for NCT02347618 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preoperative SBRT is the first listed.
NCT02347618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02347618 about?
NCT02347618 is a clinical study titled "Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer". The purpose of this study is to determine whether a short-course of stereotactic body radiotherapy (SBRT) prior to surgical resection of pancreatic adenocarcinoma is feasible and well-tolerated.
What is the current status of trial NCT02347618?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-12. Estimated completion is 2022-04-13.
What interventions are being tested in trial NCT02347618?
The interventions under investigation include: Preoperative SBRT (RADIATION).
Who is sponsoring clinical trial NCT02347618?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.